David L Tait
Affiliation: Carolinas Medical Center
- A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group studyDavid L Tait
Carolinas Medical Center, Blumenthal Cancer Center, Charlotte, NC 28203, USA
Gynecol Oncol 121:118-21. 2011..The study aims to evaluate the anti-tumor activity and toxicity of gemcitabine in patients with persistent or recurrent endometrial carcinoma...
- Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancerZahra Bahrani-Mostafavi
Cannon Research Center, Molecular Biology Core Facility, Carolinas Medical Center, Charlotte, NC 28203, USA
Cancer Invest 26:990-8. 2008..Our data indicates that the significantly modeled relationships between HOX, ErbB and IGFBP gene pairs could provide insight into the underlying biological mechanisms in ovarian cancer...